The Division of Infectious Diseases offers superior inpatient and outpatient care and consultation services to meet the challenges posed by pediatric infectious diseases. They are leaders in infection prevention and antimicrobial stewardship both at CHLA and nationally.
Each year, our physicians consult on more 1,000 hospitalized patients with complex bacterial, fungal and viral infections in all organ systems.
In addition, our physicians provide telephone consultations to hundreds of providers within California and the rest of the United States and are actively involved in graduate medical education through the USC Keck School of Medicine.
Commonly Treated Conditions
- Bone and joint infections
- Complex pneumonias
- Infections in transplant and immunocompromised patients
- Multidrug-resistant bacterial infections
- Post-surgical infections
- Toxic shock syndrome
- Travel-related infections
Areas of Research
- Antimicrobial pharmacokinetics/pharmacodynamics and precision medicine
- Antimicrobial Stewardship
- Bacterial pathogenesis, particularly Mycobacterium abscessus (new program)
- Clinical microbiologic diagnostics
- Ebola virus disease
- Emerging infectious diseases
- Infection prevention and control
- Infections in immunocompromised hosts
- Long COVID
- Medical education in low-resource settings
- Neglected tropical diseases
- Pandemic response preparation and training
Along with members of the Department of Pathology and Laboratory Medicine, the Division of Infectious Diseases is participating in a collaborative initiative to translate innovative scientific research into novel diagnostics, therapeutic and preventive strategies for important microbial pathogens affecting immunocompromised patients.
The focus of this research is on fungal and mycobacterial organisms, especially Aspergillus species.